Akt

Akt inhibitors target Akt, also called protein kinase B (PKB), a serine/threonine kinase in cell survival signaling. In 1995 the Akt proto-oncogene product was identified as a target of phosphatidylinositol 3-kinase (PI3K) activated by platelet-derived growth factor. Insulin and insulin-like growth factor 1 activate the kinase through phosphorylation at Thr308 and Ser473. The three isoforms, Akt1, Akt2 and Akt3, phosphorylate substrates that control metabolism, proliferation and apoptosis. The category includes the allosteric inhibitor MK-2206 2HCl, the catalytic-site inhibitor capivasertib and the alkylphospholipid perifosine. SC79, by contrast, promotes Akt phosphorylation and serves as an activator in pathway studies.

Items 126-150 of 218

  • AKT-IN-12
    Cat. No.
    A25690

    AKT-IN-12

    AKT-IN-12 is a selective Akt kinase inhibitor, exhibiting an IC50 value of 0.55 μM. It effectively induces G0/G1 cell cycle arrest and promotes apoptosis in target cells. Additionally, AKT-IN-12 inhibits phosphorylated AKT and ERK while activating JNK and phosphorylated JNK, making it a valuable reagent for research applications in leukemia studies.

    Out of stock

    All 3 sizes
  • AKT-IN-20
    Cat. No.
    A25692

    AKT-IN-20

    AKT-IN-20 is a selective inhibitor of the AKT kinase, a key regulator in numerous signaling pathways involved in cell growth, survival, and metabolism. This compound effectively impedes AKT activity, making it valuable for the study of cancer mechanisms and the exploration of potential therapeutic strategies. Its application is essential for researchers investigating the role of AKT in tumorigenesis and treatment resistance.

    1 mg
    $110.00
    2 mg
    $155.00
    All 8 sizes
  • Archexin
    Cat. No.
    A25704

    Archexin

    Synonyms: RX-0201

    Archexin is an antisense oligonucleotide designed to inhibit the synthesis of Akt1. This reagent effectively reduces Akt1 expression, making it a valuable tool for studying the role of Akt signaling in metastatic renal cancer. Its application in research facilitates the exploration of potential therapeutic strategies targeting the Akt pathway.

    Out of stock

    All 3 sizes
  • Ipatasertib tosylate
    Cat. No.
    A25706

    Ipatasertib tosylate

    Synonyms: GDC-0068 tosylate; RG7440 tosylate

    Ipatasertib tosylate is a potent and selective ATP-competitive inhibitor of pan-Akt, exhibiting IC50 values of 5, 18, and 8 nM for Akt1, Akt2, and Akt3, respectively. By inhibiting Akt, Ipatasertib tosylate activates FoxO3a and NF-κB, resulting in p53-independent activation of PUMA and subsequent apoptosis in cancer cells. This compound demonstrates significant anti-tumor activity in xenograft mouse models, making it a valuable tool for cancer research and therapeutic development.

    Out of stock

    All 3 sizes
  • AKT-IN-22
    Cat. No.
    A25708

    AKT-IN-22

    AKT-IN-22 is a potent allosteric inhibitor of AKT, a key kinase involved in various cellular processes such as proliferation, survival, and glucose metabolism. Its inhibition of AKT has demonstrated significant anticancer effects, making it a valuable tool for cancer research. This compound is particularly useful for studying the mechanisms of AKT signaling pathways and exploring therapeutic strategies in oncology.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Doxazosin hydrochloride
    Cat. No.
    A25709

    Doxazosin hydrochloride

    Synonyms: UK 33274 hydrochloride

    Doxazosin hydrochloride is an Akt inhibitor that primarily targets postsynaptic α1-adrenoceptors in vascular smooth muscle. This compound exhibits vasodilatory effects, resulting in decreased peripheral vascular resistance, and is utilized in studies of hypertension and prostate hyperplasia. Additionally, Doxazosin hydrochloride has demonstrated the ability to inhibit the proliferation and migration of hepatic stellate cells in mouse liver fibrosis models, influencing fibrosis, autophagy, and apoptosis mechanisms through the activation of the PI3K/Akt/mTOR signaling pathway. It also disrupts autophagic flux, leading to enhanced apoptosis in hepatic stellate cells.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • AKT-IN-25
    Cat. No.
    A25711

    AKT-IN-25

    AKT-IN-25 is a selective inhibitor of Akt that targets its phosphorylation, thereby disrupting the PI3K/Akt/mTOR signaling pathway. This compound effectively arrests the cell cycle at the G1 phase and inhibits the migration and proliferation of pancreatic cancer cells, including PANC-1, PATU-T, and SUIT-2, with IC50 values of 3.05 μM, 1.32 μM, and 3.85 μM, respectively. AKT-IN-25 is a valuable tool for studying Akt-mediated cellular processes and therapeutic strategies in cancer research.

    Out of stock

    All 3 sizes
  • Acetyl-Exenatide
    Cat. No.
    A25712

    Acetyl-Exenatide

    Acetyl-Exenatide is an acetylated derivative of Exenatide, targeting the PI3K/Akt signaling pathway. This compound exhibits insulin-mimetic properties and is instrumental in type 2 diabetes research. Acetyl-Exenatide promotes Th17 differentiation while inhibiting Treg differentiation, and downregulates the phosphorylation of PI3K/Akt/FoxO1, making it a valuable tool for elucidating mechanisms underlying metabolic disorders.

    Out of stock

    All 3 sizes
  • SH-5
    Cat. No.
    A25715

    SH-5

    SH-5 is a potent inhibitor of the AKT signaling pathway. It enhances apoptosis triggered by tumor necrosis factor (TNF) and effectively blocks NF-kB activation induced by TNF-α, lipopolysaccharide, phorbol ester, and cigarette smoke. This compound is valuable for research applications involving cell survival, inflammation, and cancer biology.

    25 mg
    $1,275.00
    All 1 sizes
  • NISC-6
    Cat. No.
    A25723

    NISC-6

    NISC-6 is a dual inhibitor of Topoisomerase IIα and Akt, demonstrating significant inhibitory activity in various cancer cell lines, including UACC903 (IC50 = 2.5 µM) and CHL-1 (IC50 = 0.8 µM). This compound effectively induces both early and late apoptosis in a dose-dependent manner. NISC-6 is suitable for research focusing on melanoma and related therapeutic mechanisms.

    Out of stock

    All 3 sizes
  • Akt/SKG Substrate Peptide
    Cat. No.
    A25725

    Akt/SKG Substrate Peptide

    Akt/SKG Substrate Peptide is a synthetic peptide specifically designed as a substrate for Akt/PKB. This peptide is selectively phosphorylated by Akt/PKB and does not undergo phosphorylation by p70S6K or MAPK1, making it an ideal tool for studying the Akt signaling pathway. Its specificity is valuable in research applications focused on cancer, metabolism, and neurological disorders associated with Akt dysregulation.

    1 mg
    $290.00
    All 1 sizes
  • Calebin A
    Cat. No.
    A25726

    Calebin A

    Calebin A is a potent inhibitor of the PI3K/Akt/mTOR pathway, as well as MAPK and NF-κB signaling pathways. It exhibits significant anti-tumor activity through epigenetic regulation and can suppress apoptosis while inhibiting autophagy. Additionally, Calebin A modulates adipogenesis, enhances thermogenic processes, and supports gut microbiota. This compound is suitable for research in various domains, including osteoarthritis, Alzheimer's disease, type 2 diabetes, malignant peripheral nerve sheath tumors, and colorectal cancer.

    1 mg
    $155.00
    5 mg
    $395.00
    All 6 sizes
  • AKT1-IN-11
    Cat. No.
    A25731

    AKT1-IN-11

    AKT1-IN-11 is a dual inhibitor targeting both AKT1 and tubulin, derived from Podophyllotoxin. This compound effectively down-regulates the phosphorylation of AKT kinase in tumor cells, leading to inhibited cell proliferation, a G2/M phase arrest, and the induction of apoptosis. Additionally, AKT1-IN-11 promotes tubulin depolymerization, making it a valuable tool for research into colorectal cancer and potential therapeutic strategies.

    Out of stock

    All 3 sizes
  • N-Arachidonoyl-L-serine
    Cat. No.
    A25732

    N-Arachidonoyl-L-serine

    Synonyms: ARA-S

    N-Arachidonoyl-L-serine is an endocannabinoid that primarily targets Akt to induce phosphorylation in endothelial cells. It facilitates endothelium-dependent vasodilation in isolated rat mesenteric and abdominal aortas. Additionally, N-Arachidonoyl-L-serine demonstrates neuroprotective effects following traumatic brain injury by reducing apoptosis. It also promotes the opening of KV7.1/KCNE1 channels in mammalian cells, shortening action potential duration in cardiomyocytes. This compound is valuable for research in cardiovascular, cerebrovascular, and neurological disorders.

    1 mg
    $40.00
    5 mg
    $150.00
    All 4 sizes
  • Akt1-IN-5
    Cat. No.
    A25735

    Akt1-IN-5

    Akt1-IN-5 is a potent Akt1 inhibitor with an IC50 of less than 15 nM. This compound selectively targets the Akt1 signaling pathway, which is crucial in regulating cell survival, metabolism, and proliferation. It is primarily used in cancer research to explore the therapeutic potential of modulating Akt1 activity in various tumor types.

    25 mg
    $1,405.00
    50 mg
    $1,790.00
    All 3 sizes
  • AS1938909
    Cat. No.
    A25736

    AS1938909

    AS1938909 is a selective Akt inducer that inhibits SHIP2 activity, leading to increased phosphorylation of Akt. This compound plays a crucial role in the regulation of glucose metabolism by upregulating GLUT1 gene expression. AS1938909 is valuable for research applications focused on metabolic disorders and signaling pathways involving Akt and SHIP2.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Akt1&PKA-IN-2
    Cat. No.
    A25747

    Akt1&PKA-IN-2

    Akt1&PKA-IN-2 (Compound R-29) is a AKT1 and PKA inhibitor with selectivity for CDK2, with IC50 values of 0.007 and 0.01 μM, respectively. Akt1&PKA-IN-2 is applicable for cancer research.

    1 mg
    $130.00
    5 mg
    $290.00
    All 6 sizes
  • XL-418
    Cat. No.
    A25749

    XL-418

    XL-418 is a potent dual inhibitor of Akt and p70S6K, demonstrating IC50 values of 1 nM for Akt1 and 2 nM for p70S6K. This compound effectively inhibits the phosphorylation of ribosomal protein S6 and GSK3β, making it a valuable tool in cancer research. XL-418 is particularly relevant for studies involving prostate carcinoma and breast cancer, contributing to the understanding of signaling pathways in tumorigenesis.

    5 mg
    $180.00
    10 mg
    $295.00
    All 5 sizes
  • MS143
    Cat. No.
    A25750

    MS143

    MS143 is a potent PROTAC degrader targeting AKT, demonstrating a DC50 of 46 nM and GI50 of 0.8 μM in PC3 cells. This compound effectively induces rapid and robust AKT degradation through the hijacking of the ubiquitin-proteasome system in a concentration- and time-dependent manner. MS143 holds promise in cancer research for its ability to suppress cell growth by promoting targeted protein degradation.

    1 mg
    $205.00
    5 mg
    $600.00
    All 2 sizes
  • AKT-IN-23
    Cat. No.
    A25756

    AKT-IN-23

    AKT-IN-23 is a selective inhibitor of the AKT kinase, a crucial component in the PI3K/AKT signaling pathway. This compound effectively inhibits AKT activity, leading to decreased cell proliferation and survival in various cancer cell models. AKT-IN-23 is useful in cancer research, particularly in studies focused on the modulation of signaling pathways associated with tumor progression and therapeutic resistance.

    5 mg
    $195.00
    10 mg
    $325.00
    All 5 sizes
  • Hu7691 free base
    Cat. No.
    A25758

    Hu7691 free base

    Hu7691 free base is a selective inhibitor of AKT, demonstrating IC50 values of 4.0 nM, 97.5 nM, and 28 nM for AKT1, AKT2, and AKT3, respectively. This compound exhibits significant antitumor activity and has been shown to reduce cutaneous toxicity in murine models. Hu7691 free base is valuable in research focused on cancer therapeutics and the modulation of the AKT signaling pathway.

    1 mg
    $235.00
    5 mg
    $590.00
    All 5 sizes
  • MS98
    Cat. No.
    A25760

    MS98

    MS98 is a selective PROTAC degrader targeting AKT, effectively inducing the degradation of total AKT (T-AKT) with a DC50 value of 78 nM. This compound demonstrates high-affinity binding to AKT isoforms, with Kd values of 4 nM, 140 nM, and 8.1 nM for AKT1, AKT2, and AKT3, respectively. MS98 is valuable for research applications in understanding AKT signaling pathways and developing therapeutic strategies for cancer and other diseases associated with dysregulated AKT activity.

    25 mg
    $1,275.00
    All 1 sizes
  • AT7867 hydrochloride
    Cat. No.
    A25763

    AT7867 hydrochloride

    AT7867 hydrochloride is a potent inhibitor of AKT and p70 S6 kinase, exhibiting strong oral activity. This compound demonstrates significant anticancer properties, making it a valuable tool in cancer research. Its efficacy in targeting critical signaling pathways involved in cellular growth and survival supports its use in exploring therapeutic strategies for various malignancies.

    10 mg
    $330.00
    50 mg
    $1,380.00
    All 2 sizes
  • MK-2206 free base
    Cat. No.
    A25765

    MK-2206 free base

    MK-2206 free base is a highly potent and selective allosteric inhibitor of the Akt signaling pathway, exhibiting IC50 values of 8 nM, 12 nM, and 65 nM for Akt1, Akt2, and Akt3, respectively. This compound demonstrates significant anticancer properties, particularly against breast cancer cell lines, as well as those harboring PIK3CA mutations and PTEN loss. MK-2206 free base is valuable for research applications focused on cancer biology and therapeutic development targeting the Akt pathway.

    Out of stock

    All 3 sizes
  • AKT-IN-5
    Cat. No.
    A25769

    AKT-IN-5

    AKT-IN-5 is a selective inhibitor of Akt1 and Akt2, exhibiting IC50 values of 450 nM and 400 nM, respectively. This compound has been shown to effectively modulate the Akt signaling pathway, which plays a critical role in cell survival, proliferation, and metabolism. AKT-IN-5 is valuable for research applications focused on cancer biology, metabolic disorders, and other conditions driven by aberrant Akt activity.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes

Items 126-150 of 218

Added to your cart

View Cart Checkout

    Loading...